| 000 | 01648 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517145939.0 | ||
| 264 | 0 | _c20170920 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1521-4141 | ||
| 024 | 7 |
_a10.1002/eji.201746934 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaselmayer, Philipp | |
| 245 | 0 | 0 |
_aA mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells. _h[electronic resource] |
| 260 |
_bEuropean journal of immunology _c06 2017 |
||
| 300 |
_a1075-1085 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutoantibodies _xbiosynthesis |
| 650 | 0 | 4 | _aAutoimmunity |
| 650 | 0 | 4 |
_aB-Cell Activating Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aB-Cell Activation Factor Receptor _xadministration & dosage |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aKidney _ximmunology |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPlasma Cells _ximmunology |
| 650 | 0 | 4 |
_aTransmembrane Activator and CAML Interactor Protein _xadministration & dosage |
| 650 | 0 | 4 |
_aTumor Necrosis Factor Ligand Superfamily Member 13 _xantagonists & inhibitors |
| 700 | 1 | _aVigolo, Michele | |
| 700 | 1 | _aNys, Josquin | |
| 700 | 1 | _aSchneider, Pascal | |
| 700 | 1 | _aHess, Henry | |
| 773 | 0 |
_tEuropean journal of immunology _gvol. 47 _gno. 6 _gp. 1075-1085 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/eji.201746934 _zAvailable from publisher's website |
| 999 |
_c27055250 _d27055250 |
||